Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma
Hepatology Research2018Vol. 49(1), pp. 51–63
Citations Over TimeTop 10% of 2018 papers
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Hiroko Shindo, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto
Abstract
Patients with low HBsAg/high HBcrAg values are at high risk of developing HBV-related HCC, according to this cross-sectional and longitudinal analysis, indicating that the combination of HBsAg and HBcrAg values is an excellent biomarker for assessing HCC risk.
Related Papers
- → Experimental study of the inhibitory effect of gantai capsule on HBsAg and HBeAg expression(2002)1 cited
- Inhibition of HBsAg and HBeAg Expression by ASODN of Various Regions of the HBV Genome(2005)
- Inhibitory effect of extracts of the core of lithion the expression of HBsAg and HBeAg in the HepG 2.2.15 cells(2004)
- Inhibitory effect of FFYC tablets(FFYC) on expression of HBsAg and HBeAg(2004)
- Experimental Study of the Inhibitory Effect of Gantai Capsule (肝泰胶囊) on HBsAg and HBeAg Expression(2002)